US Stock MarketDetailed Quotes
TRAW Traws Pharma
- 4.510
- +0.020+0.45%
Close Nov 21 16:00 ET
13.65MMarket Cap-33P/E (TTM)
4.850High4.320Low3.87KVolume4.320Open4.490Pre Close17.91KTurnover0.17%Turnover RatioLossP/E (Static)3.03MShares27.50052wk High-6.71P/B10.30MFloat Cap4.15552wk Low--Dividend TTM2.28MShs Float1751062.500Historical High--Div YieldTTM11.80%Amplitude4.155Historical Low4.628Avg Price1Lot Size
About Traws Pharma Company
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
Company Profile
SymbolTRAW
Company NameTraws Pharma
Listing DateJul 25, 2013
Founded1998
CEOMr. Werner Cautreels PhD
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address12 Penns Trail
CityNewtown
ProvincePennsylvania
CountryUnited States of America
Zip Code18940-3423
Phone1-267-759-3680
Websitehttp://www.trawspharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Werner Cautreels, PhD
- Director and Chief Executive Officer
- --
- Dr. Nikolay Savchuk
- Director and Chief Operating Officer
- --
- Mark P. Guerin
- Chief Financial Officer and Principal Accounting Officer
- 745.52K
- Dr. Robert Redfield
- Chief Medical Officer
- --
- Dr. Victor M. Moyo, M.D.
- Chief Medical Officer, Oncology
- 405.24K
- Dr. Charles David Pauza, PhD
- Chief Scientific Officer, Virology
- --
- Dr. Iain D. Dukes, D.Phil.
- Executive Chairman of the Board
- --
- Luba Greenwood
- Director
- --
- Mary Teresa Shoemaker
- Independent Director
- 118.22K
- Dr. Trafford Clarke, PhD
- Independent Director
- 104.22K
- Jack E. Stover
- Independent Director
- 126.72K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data